Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Ontology Browser

Term:
EC 3.1.1.3 (triacylglycerol lipase) inhibitor (CHEBI:65001)
Annotations: Rat: (3532) Mouse: (3586) Human: (3771) Chinchilla: (0) Bonobo: (0) Dog: (2) Squirrel: (0) Pig: (15)
Parent Terms Term With Siblings Child Terms
EC 3.1.1.1 (carboxylesterase) inhibitor +   
EC 3.1.1.3 (triacylglycerol lipase) inhibitor +   
Any EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that inhibits the action of triacylglycerol lipase (EC 3.1.1.3).
EC 3.1.1.4 (phospholipase A2) inhibitor +   
EC 3.1.1.5 (lysophospholipase) inhibitor +  
EC 3.1.1.64 (retinoid isomerohydrolase) inhibitor +   
EC 3.1.1.7 (acetylcholinesterase) inhibitor +   
EC 3.1.1.8 (cholinesterase) inhibitor +   

Synonyms
Related Synonyms: EC 3.1.1.3 inhibitor ;   EC 3.1.1.3 inhibitors ;   GEH inhibitor ;   GEH inhibitors ;   PPL inhibitor ;   PPL inhibitors ;   Tween hydrolase inhibitor ;   Tween hydrolase inhibitors ;   Tweenase inhibitor ;   Tweenase inhibitors ;   Tweenesterase inhibitor ;   Tweenesterase inhibitors ;   butyrinase inhibitor ;   butyrinase inhibitors ;   cacordase inhibitor ;   cacordase inhibitors ;   capalase L inhibitor ;   capalase L inhibitors ;   glycerol ester hydrolase inhibitor ;   glycerol-ester hydrolase inhibitors ;   heparin releasable hepatic lipase inhibitor ;   heparin releasable hepatic lipase inhibitors ;   hepatic lipase inhibitor ;   hepatic lipase inhibitors ;   hepatic monoacylglycerol acyltransferase inhibitor ;   hepatic monoacylglycerol acyltransferase inhibitors ;   lipase inhibitor ;   lipase inhibitors ;   lipazin inhibitor ;   lipazin inhibitors ;   liver lipase inhibitor ;   liver lipase inhibitors ;   pancreatic lipase inhibitor ;   pancreatic lipase inhibitors ;   pancreatic triacylglycerol lipase inhibitor ;   pancreatic triacylglycerol lipase inhibitors ;   post-heparin plasma protamine-resistant lipase inhibitor ;   post-heparin plasma protamine-resistant lipase inhibitors ;   salt-resistant post-heparin lipase inhibitor ;   salt-resistant post-heparin lipase inhibitors ;   steapsin inhibitor ;   steapsin inhibitors ;   triacetinase inhibitor ;   triacetinase inhibitors ;   triacylglycerol ester hydrolase inhibitor ;   triacylglycerol ester hydrolase inhibitors ;   triacylglycerol lipase (EC 3.1.1.3) inhibitors ;   triacylglycerol lipase inhibitor ;   triacylglycerol lipase inhibitors ;   tributyrase inhibitor ;   tributyrase inhibitors ;   tributyrin esterase inhibitor ;   tributyrin esterase inhibitors ;   tributyrinase inhibitor ;   tributyrinase inhibitors ;   triglyceridase inhibitor ;   triglyceridase inhibitors ;   triglyceride hydrolase inhibitor ;   triglyceride hydrolase inhibitors ;   triglyceride lipase inhibitor ;   triglyceride lipase inhibitors ;   triolein hydrolase inhibitor ;   triolein hydrolase inhibitors ;   tween-hydrolysing esterase inhibitor ;   tween-hydrolyzing esterase inhibitors

paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.